AAMU
PTCT icon

Amundi Asset Management US’s PTC Therapeutics PTCT Stock Holding History

Amundi Asset Management US’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$52K Hold
1,100
– – ﹤0.01% 1508
2020
Q4 		$67K Hold
1,100
– – ﹤0.01% 1439
2020
Q3 		$51K Buy
+1,100
New +$54.2K ﹤0.01% 1446

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Amundi Asset Management US's PTCT Position: Q1 2021 in Review

Amundi Asset Management US held its PTC Therapeutics (PTCT) position steady in Q1 2021 at 1,100 shares worth $52K. The position accounts for ﹤0.01% of the portfolio, ranked #1508.

Amundi Asset Management US first reported a position in PTCT in Q3 2020 and has held it in 3 quarters since. The position peaked at $67K in Q4 2020. 208 funds tracked by Wall St. Rank hold PTCT as of Q1 2021.

  • Amundi Asset Management US held 1,100 shares of PTC Therapeutics worth $52K as of Q1 2021.
  • Amundi Asset Management US left its PTC Therapeutics share count unchanged in Q1 2021.
  • PTC Therapeutics made up ﹤0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #1508 holding.
  • Amundi Asset Management US first reported a position in PTC Therapeutics in Q3 2020 and has held it in 3 quarters since.
  • Amundi Asset Management US's PTC Therapeutics position peaked at $67K in Q4 2020.
  • 208 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.